Chronic conditions such as back pain, musculoskeletal pain,neuropathic pain, and cancer pain, often resistant to conventional treatments, can be managed effectively through percutaneous techniques.

The goal in treating ulcerative colitis is to reduce the inflammation, hopefully leading to remission. The two leading treatment options are medication and surgery. Approximately 70 percent of ...

"This could provide a better understanding of the occurrence of chronic cough, which may ultimately result in better treatments for this difficult-to-treat condition." Emilsson and his colleagues ...

This is particularly true for chronic diseases. For example, diabetes mellitus is defined biochemically ... Undoubtedly, health technology will continue to advance so that in the future we can see ...

The vulnerability to infection of people with chronic diseases highlighted the need for research into treatment of not only covid-19 but also chronic diseases. New technology was developed to promote ...

[3] CT scans in patients with chronic sinusitis will allow ... a practicing physician for 30 years. Ransom JH. Sinusitis: Diagnosis and Treatment. MedGenMed 1(1), 1999 [formerly published in ...

The data published in The Lancet is being heralded as a big breakthrough in the treatment of cervical cancer and uses readily available chemotherapy drugs, given to patients before they receive ...

One can opt for medical treatments or lifestyle modifications depending upon the symptoms and risk factors associated with it. Chronic back pain should not be ignored, and you should go for ...

As I reflect on how we can more effectively bring treatments to patients, one central question emerges: How can we transform scientific discoveries into better treatments? The intersection of ...

The overall incidence and severity of treatment-emergent adverse events ... nasal polyp growth and nasal obstruction.” CRSwNP is a chronic condition that affects up to 4% of the general ...

That recurrence, and exploring new treatments for this common infection, is the subject of a new three-year National Institutes of Health-backed study at Salve Regina University. In mid-September ...

Chronic rhinosinusitis with nasal polyps has caught the attention of drugmakers since ... Dupixent, which has become one of the pharmaceutical industry’s top-selling drugs, was approved as an add-on ...